Evolutionary dynamics of residual disease in human glioblastoma

Date

2019-03-01

Author

Spiteri, I.
Caravagna, G.
Cresswell, G. D.
Vatsiou, A.
Nichol, D.
Acar, Ahmet
Ermini, L.
Chkhaidze, K.
Werner, B.
Mair, R.
Brognaro, E.
Verhaak, R. G. W.
Sanguinetti, G.
Piccirillo, S. G. M.
Watts, C.
Sottoriva, A.

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

123
views

0
downloads

Background Glioblastoma is the most common and aggressive adult brain malignancy against which conventional surgery and chemoradiation provide limited benefit. Even when a good treatment response is obtained, recurrence inevitably occurs either locally (approximate to 80%) or distally (approximate to 20%), driven by cancer clones that are often genomically distinct from those in the primary tumour. Glioblastoma cells display a characteristic infiltrative phenotype, invading the surrounding tissue and often spreading across the whole brain. Cancer cells responsible for relapse can reside in two compartments of residual disease that are left behind after treatment: the infiltrated normal brain parenchyma and the sub-ventricular zone. However, these two sources of residual disease in glioblastoma are understudied because of the difficulty in sampling these regions during surgery.

URI

https://hdl.handle.net/11511/89495

Journal

ANNALS OF ONCOLOGY

DOI

https://doi.org/10.1093/annonc/mdy506

Collections

Department of Biology, Article

Suggestions

OpenMETU
Core

Temporal changes in the gene expression heterogeneity during brain development and aging Isildak, Ulas; Somel, Mehmet; Thornton, Janet M.; Donertas, Handan Melike (Springer Science and Business Media LLC, 2020-03-01) Cells in largely non-mitotic tissues such as the brain are prone to stochastic (epi-)genetic alterations that may cause increased variability between cells and individuals over time. Although increased interindividual heterogeneity in gene expression was previously reported, whether this process starts during development or if it is restricted to the aging period has not yet been studied. The regulatory dynamics and functional significance of putative aging-related heterogeneity are also unknown. Here we ad...
Dual growth factor delivery using PLGA nanoparticles in silk fibroin/PEGDMA hydrogels for articular cartilage tissue engineering Fathi-Achachelouei, Milad; Keskin, Dilek; Bat, Erhan; Vrana, Nihal E.; Tezcaner, Ayşen (Wiley, 2020-07-01) Degeneration of articular cartilage due to damages, diseases, or age-related factors can significantly decrease the mobility of the patients. Various tissue engineering approaches which take advantage of stem cells and growth factors in a three-dimensional constructs have been used for reconstructing articular tissue. Proliferative impact of basic fibroblast growth factor (bFGF) and chondrogenic differentiation effect of transforming growth factor-beta 1 (TGF-beta 1) over mesenchymal stem cells have previou...
Transcriptomic network analysis of brain aging and alzheimers disease Parvizi, Poorya; Somel, Mehmet; Tunçbağ, Nurcan; Department of Biology (2017) Multiple studies have investigated aging brain transcriptomes to identify for age-dependent expression changes and determine genes that may participate in age-related dysfunction. However, aging is a highly complex and heterogeneous process where multiple genes contribute at different levels depending on individuals’ environments and genotypes. Both this biological heterogeneity of aging, as well as technical biases and weaknesses inherent to transcriptome measurements, limit the information gained from a s...
Targeted liposomes for cell death imaging and amplified drug delivery RİCE, Douglas; Türkyılmaz, Serhan; PALUMBO, Rachael; HARMATYS, Kara; SMİTH, Bradley D (2013-03-02) The goal is to develop liposomes that have selective affinity for dead and dying cells, and then use the liposomes as targeted imaging agents for rapidly assessing the efficacy of anticancer therapies. A subsequent application is to use the liposomes to deliver anticancer drugs to tumors and initiate cell death processes that amplify the liposome targeting at later time points in the therapy. The liposome surface is decorated with 2% Zn-DPA-PEG2000-PE, an anchored phospholipid with an extended polyethylene ...
Metabolomics analysis of iPSCs derived organoids Sarı , Vedat; Koçak , Gamze; Reçber, Tuba; Karakülah , Gökhan; Utine , Canan Aslı; Nemutlu , Emirhan; Güven, Sinan (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10) Regenerative medicine is focused on functional restoration of a particular tissue and organs. Stem cell based miniaturized heterogenous cellular clusters named organoids, exhibit features of organ functionality, self-organization, multicellularity, and utility. Induced pluripotent stem cells (iPSCs), have great potential to develop organoids of specific tissues and utilized in regenerative medicine. Organoid technologies have revolutionized the approach to human development and diseases, providing outstandi...

Citation Formats

I. Spiteri et al., “Evolutionary dynamics of residual disease in human glioblastoma,” ANNALS OF ONCOLOGY, pp. 456–463, 2019, Accessed: 00, 2021. [Online]. Available: https://hdl.handle.net/11511/89495.